Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (254)	1/30/2003 3:44:29 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

BPUR Is up more than 11% on volume of 379.65K (more than 3x its daily average.) That is in spite of the fact that its auditors (Ernst & Young) raised the question of it being a "going concern" in view of its dire cash situation. But BPUR has announced that it has restructured the company to improve organizational efficiency and facilitate its transition "from research and development to a fully commercialized, global pharmaceutical manufacturing company."<g> siliconinvestor.com If BPUR can close above its Jan.28 H of 2.75 it is still facing a good deal of resistance at the 3.00 and 3.25 levels before it can test its long term average, presenttly at 3.75 <g> siliconinvestor.com Bernard